Effect of a Prebiotic Formulation on Frailty Syndrome: A Randomized, Double-Blind Clinical Trial

By Buigues Cristina   Fernández-Garrido Julio   Pruimboom Leo   Hoogland Aldert J.   Navarro-Martínez Rut   Martínez-Martínez Mary   Verdejo Yolanda   Mascarós Mari Carmen   Peris Carlos   Cauli Omar  

International Journal of Molecular Sciences, Vol. 17, Iss. 6, 2016-06 ,pp. : 932-932

MDPI

Access to resources Recommend Favorite

The Effect of Low-Dose Marine n-3 Fatty Acids on Plasma Levels of sCD36 in Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial

By Venø Stine Krogh   Nielsen Michael René Skjelbo   Lundbye-Christensen Søren   Schmidt Erik Berg   Handberg Aase  

Marine Drugs, Vol. 11, Iss. 9, 2013-08 ,pp. : 3324-3334

MDPI

Access to resources Recommend Favorite

A Randomized, Double‐Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density

By  

JOURNAL OF BONE AND MINERAL RESEARCH, Vol. 30, Iss. 2, 2015-02 ,pp. : 216-224

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of a Combination of Berberis aristata, Silybum marianum and Monacolin on Lipid Profile in Subjects at Low Cardiovascular Risk; A Double-Blind, Randomized, Placebo-Controlled Trial

By Giuseppe Derosa   Angela D’Angelo   Davide Romano   Pamela Maffioli  

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-02 ,pp. : 343-343

MDPI

Access to resources Recommend Favorite

Randomized trial of peginterferon alpha‐2b plus low and escalating dose of ribavirin in patients with chronic hepatitis C with high viral load genotype 1

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 87, Iss. 4, 2015-04 ,pp. : 625-633

John Wiley & Sons Inc

Access to resources Recommend Favorite